AI-Driven Imaging Analysis Reveals Neuroprotective Benefits of ARG-007 CHICAGO / OXFORD: Artificial intelligence-powered imaging from Brainomix has played a pivotal role in identifying the therapeutic benefit of ARG-007, a novel neuroprotective drug candidate, in patients suffering from severe acute ischemic stroke. The analysis was conducted as part of a Phase II clinical study by Argenica Therapeutics, with Brainomix providing imaging standardisation and data […]

AI-Driven Imaging Analysis Reveals Neuroprotective Benefits of ARG-007 #AI #Neuroprotection #ImagingAnalysis #StrokeResearch #ClinicalTrials